Abstract
AbstractWhile there are emerging reports in the scientific literature on potential associations between cholesterol/lipids and prostate cancer, information on the dietary management of these cancer patients is currently lacking. We report on a 57-year-old white Australian male diagnosed with advanced prostate cancer who had personalized dietary management in preparation for and following his medical treatment: radiation and radical prostatectomy. Dietary recommendations were based on his blood results and nutrigenomic tests which showed a history of and genetic predisposition to dyslipidemia. Nutritional analysis also confirmed the need for dietary modification of his fat intake. Eighteen months post medical and dietary intervention his PSA level was reported at 0.1 ug/L and all blood lipid levels were within reference ranges. At two years there was no detectable disease recurrence and androgen deprivation therapy (ADT) was not required. Personalized dietary recommendations could be a clinically beneficial addition to the multidisciplinary management of prostate cancer patients.
Publisher
Springer Science and Business Media LLC
Subject
Nutrition and Dietetics,Medicine (miscellaneous)
Reference9 articles.
1. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report. In: Diet, nutrition, physical activity and prostate cancer. 2018. https://www.wcrf.org/wp-content/uploads/2021/02/prostate-cancer-report.pdf. Accessed 16 Jan 2022.
2. Raftopulos NL, Washaya TC, Niederprum A, Egert A, Hakeem-Sanni MF, Varney B. et al. Prostate cancer cell proliferation isinfluenced by LDL-cholesterol availability and cholesteryl ester turnover. Cancer Metab. 2022;10:1 https://doi.org/10.1186/s40170-021-00278-1.
3. Siltari A, Syvala H, Lou YR, Gao Y, Murtola TJ. Role of lipids and lipid metabolism in prostate cancer progression and the tumor’s immune environment. Cancers. 2022;14:4293 https://doi.org/10.3390/cancers14174293
4. Butler LM, Centenera MM, Swinnen JV. Androgen control of lipid metabolism in prostate cancer: novel insights and future applications. Endocr Relat Cancer. 2016;23:R219–27.
5. Bradic M, Costa J, Chelo IM. Genotyping with sequenom. Methods Mol Biol. 2011;772:193–210.